i3 Health has developed the “Understanding Evolving Treatment Paradigms in Advanced Hepatocellular Carcinoma.

Learning objectives include :

  • Identify prognostic factors that can inform personalized care plans for patients with HCC
  • Assess emerging data on the use of novel therapies in first-line, second-line, and salvage therapy for advanced HCC
  • Apply strategies to manage adverse events and help patients with advanced HCC achieve their goals of therapy

Check back frequently as we continue to update with new opportunities. If you would like to submit a liver cancer CME activity for consideration for posting on Liver Central, please email